These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 7622455
21. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Mackay AR, Ballin M, Pelina MD, Farina AR, Nason AM, Hartzler JL, Thorgeirsson UP. Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126 [Abstract] [Full Text] [Related]
22. Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. Shamamian P, Schwartz JD, Pocock BJ, Monea S, Whiting D, Marcus SG, Mignatti P. J Cell Physiol; 2001 Nov; 189(2):197-206. PubMed ID: 11598905 [Abstract] [Full Text] [Related]
23. The catalytic domain of activated collagenase I (MMP-1) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 (TIMP-1). Vallon R, Müller R, Moosmayer D, Gerlach E, Angel P. Eur J Biochem; 1997 Feb 15; 244(1):81-8. PubMed ID: 9063449 [Abstract] [Full Text] [Related]
24. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Delclaux C, Delacourt C, D'Ortho MP, Boyer V, Lafuma C, Harf A. Am J Respir Cell Mol Biol; 1996 Mar 15; 14(3):288-95. PubMed ID: 8845180 [Abstract] [Full Text] [Related]
25. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. Fernandez-Catalan C, Bode W, Huber R, Turk D, Calvete JJ, Lichte A, Tschesche H, Maskos K. EMBO J; 1998 Sep 01; 17(17):5238-48. PubMed ID: 9724659 [Abstract] [Full Text] [Related]
27. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP). Worley JR, Thompkins PB, Lee MH, Hutton M, Soloway P, Edwards DR, Murphy G, Knäuper V. Biochem J; 2003 Jun 15; 372(Pt 3):799-809. PubMed ID: 12630911 [Abstract] [Full Text] [Related]
28. Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblasts. Ito A, Nakajima S, Sasaguri Y, Nagase H, Mori Y. Br J Cancer; 1995 May 15; 71(5):1039-45. PubMed ID: 7734296 [Abstract] [Full Text] [Related]
32. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation. Reynolds JJ. Oral Dis; 1996 Mar 15; 2(1):70-6. PubMed ID: 8957940 [Abstract] [Full Text] [Related]
33. Direct activation of human neutrophil procollagenase by recombinant stromelysin. Knäuper V, Wilhelm SM, Seperack PK, DeClerck YA, Langley KE, Osthues A, Tschesche H. Biochem J; 1993 Oct 15; 295 ( Pt 2)(Pt 2):581-6. PubMed ID: 8240261 [Abstract] [Full Text] [Related]
34. Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis. Garratt LW, Sutanto EN, Ling KM, Looi K, Iosifidis T, Martinovich KM, Shaw NC, Kicic-Starcevich E, Knight DA, Ranganathan S, Stick SM, Kicic A, Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF). Eur Respir J; 2015 Aug 15; 46(2):384-94. PubMed ID: 25929954 [Abstract] [Full Text] [Related]
35. Endothelial-cell-stimulating angiogenesis factor (ESAF) activates progelatinase A (72 kDa type IV collagenase), prostromelysin 1 and procollagenase and reactivates their complexes with tissue inhibitors of metalloproteinases: a role for ESAF in non-inflammatory angiogenesis. McLaughlin B, Weiss JB. Biochem J; 1996 Aug 01; 317 ( Pt 3)(Pt 3):739-45. PubMed ID: 8760357 [Abstract] [Full Text] [Related]
36. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Gress TM, Müller-Pillasch F, Lerch MM, Friess H, Büchler M, Adler G. Int J Cancer; 1995 Aug 09; 62(4):407-13. PubMed ID: 7635566 [Abstract] [Full Text] [Related]
37. Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. Hernandez-Barrantes S, Toth M, Bernardo MM, Yurkova M, Gervasi DC, Raz Y, Sang QA, Fridman R. J Biol Chem; 2000 Apr 21; 275(16):12080-9. PubMed ID: 10766841 [Abstract] [Full Text] [Related]
38. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. Ramos-DeSimone N, Hahn-Dantona E, Sipley J, Nagase H, French DL, Quigley JP. J Biol Chem; 1999 May 07; 274(19):13066-76. PubMed ID: 10224058 [Abstract] [Full Text] [Related]
39. Degradation of interleukin 1beta by matrix metalloproteinases. Ito A, Mukaiyama A, Itoh Y, Nagase H, Thogersen IB, Enghild JJ, Sasaguri Y, Mori Y. J Biol Chem; 1996 Jun 21; 271(25):14657-60. PubMed ID: 8663297 [Abstract] [Full Text] [Related]
40. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. Goldberg GI, Strongin A, Collier IE, Genrich LT, Marmer BL. J Biol Chem; 1992 Mar 05; 267(7):4583-91. PubMed ID: 1311314 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]